American biotechnology company

Amgen is one of the world's largest independent biotechnology companies, dedicated to unlocking the potential of biology for patients suffering from serious illnesses. Founded in 1980, the company has pioneered the development of novel human therapeutics, including blockbuster products like Epogen, Neupogen, Enbrel, and Repatha. Amgen's research focuses on six therapeutic areas: oncology/hematology, cardiovascular disease, inflammation, bone health, nephrology, and neuroscience. The company is a leader in the development of biologics and has a robust pipeline of innovative medicines and biosimilars. With a global presence and significant manufacturing capabilities, Amgen continues to drive scientific innovation to address high unmet medical needs.